Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kornowski

Showing results (291-300 of 849) with videos related to

Pageof 85
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|November 7, 2022
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trialYeela Talmor-Barkan, Nancy-Sarah Yacovzada, Hagai Rossman, et al.
Cardiology|September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine TrialR Kornowski, U Goldbourt, H Reicher-Reiss, et al.
The Israel Medical Association Journal : IMAJ|March 17, 2016
Prevalence of Carotid Artery Disease among Ambulatory Patients with Coronary Artery DiseaseShirit Kazum, Alon Eisen, Eli I Lev, et al.
ACS Nano|February 12, 2009
Preparation and electrical properties of cobalt-platinum nanoparticle monolayers deposited by the Langmuir-Blodgett techniqueVesna Aleksandrovic, Denis Greshnykh, Igor Randjelovic, et al.
Respiratory Medicine|April 14, 2009
The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor?Gabriel Izbicki, Itsik Ben-Dor, David Shitrit, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
Israel: coronary and structural heart interventions from 2010 to 2015Ariel Finkelstein, Saar Minha, Ran Kornowski, et al.
Acute Cardiac Care|April 25, 2007
Initial experience with the Amplatzer membranous septal occluder in adultsRafael Hirsch, Avraham Lorber, Yaron Shapira, et al.
The Journal of Invasive Cardiology|December 7, 2014
Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesionsMiroslaw Ferenc, Ran Kornowski, Jorge Belardi, et al.
The Journal of Heart Valve Disease|February 24, 2016
Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Deterioration Using the Valve-in-Valve TechniquePablo Codner, Abid Assali, Hana Vaknin-Assa, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trialJens Kastrup, Erik Jørgensen, Shmuel Fuchs, et al.
Pageof 85

Showing results (291-300 of 849) with videos related to

Sort By:
Pageof 85
European Heart Journal. Cardiovascular Pharmacotherapy|November 7, 2022
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trialYeela Talmor-Barkan, Nancy-Sarah Yacovzada, Hagai Rossman, et al.
Cardiology|September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine TrialR Kornowski, U Goldbourt, H Reicher-Reiss, et al.
The Israel Medical Association Journal : IMAJ|March 17, 2016
Prevalence of Carotid Artery Disease among Ambulatory Patients with Coronary Artery DiseaseShirit Kazum, Alon Eisen, Eli I Lev, et al.
ACS Nano|February 12, 2009
Preparation and electrical properties of cobalt-platinum nanoparticle monolayers deposited by the Langmuir-Blodgett techniqueVesna Aleksandrovic, Denis Greshnykh, Igor Randjelovic, et al.
Respiratory Medicine|April 14, 2009
The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor?Gabriel Izbicki, Itsik Ben-Dor, David Shitrit, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
Israel: coronary and structural heart interventions from 2010 to 2015Ariel Finkelstein, Saar Minha, Ran Kornowski, et al.
Acute Cardiac Care|April 25, 2007
Initial experience with the Amplatzer membranous septal occluder in adultsRafael Hirsch, Avraham Lorber, Yaron Shapira, et al.
The Journal of Invasive Cardiology|December 7, 2014
Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesionsMiroslaw Ferenc, Ran Kornowski, Jorge Belardi, et al.
The Journal of Heart Valve Disease|February 24, 2016
Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Deterioration Using the Valve-in-Valve TechniquePablo Codner, Abid Assali, Hana Vaknin-Assa, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trialJens Kastrup, Erik Jørgensen, Shmuel Fuchs, et al.
Pageof 85